An analysis of supply chain strategies in the regenerative medicine industry—Implications for future development
Author
Abstract
Suggested Citation
DOI: 10.1016/j.ijpe.2013.06.006
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Galambos, Louis & Sturchio, Jeffrey L., 1998. "Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation," Business History Review, Cambridge University Press, vol. 72(2), pages 250-278, July.
- Weber, Martin, 1987. "Decision making with incomplete information," European Journal of Operational Research, Elsevier, vol. 28(1), pages 44-57, January.
- Jeffrey S. Conant & Michael P. Mokwa & P. Rajan Varadarajan, 1990. "Strategic types, distinctive marketing competencies and organizational performance: A multiple measures‐based study," Strategic Management Journal, Wiley Blackwell, vol. 11(5), pages 365-383, September.
- Robert Passier & Linda W. van Laake & Christine L. Mummery, 2008. "Stem-cell-based therapy and lessons from the heart," Nature, Nature, vol. 453(7193), pages 322-329, May.
- Heracleous, Loizos & Murray, John, 2001. "The urge to merge in the pharmaceutical industry," European Management Journal, Elsevier, vol. 19(4), pages 430-437, August.
- Oke, Adegoke & Gopalakrishnan, Mohan, 2009. "Managing disruptions in supply chains: A case study of a retail supply chain," International Journal of Production Economics, Elsevier, vol. 118(1), pages 168-174, March.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Shiva Moslemi & Mohammad Hossein Zavvar Sabegh & Abolfazl Mirzazadeh & Yucel Ozturkoglu & Eric Maass, 2017. "A multi-objective model for multi-production and multi-echelon closed-loop pharmaceutical supply chain considering quality concepts: NSGAII approach," International Journal of System Assurance Engineering and Management, Springer;The Society for Reliability, Engineering Quality and Operations Management (SREQOM),India, and Division of Operation and Maintenance, Lulea University of Technology, Sweden, vol. 8(2), pages 1717-1733, November.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- S. Arunachalam & Sridhar N. Ramaswami & Pol Herrmann & Doug Walker, 2018. "Innovation pathway to profitability: the role of entrepreneurial orientation and marketing capabilities," Journal of the Academy of Marketing Science, Springer, vol. 46(4), pages 744-766, July.
- Yoon, Junghyun & Lee, Hee Yong & Dinwoodie, John, 2015. "Competitiveness of container terminal operating companies in South Korea and the industry–university–government network," Transportation Research Part A: Policy and Practice, Elsevier, vol. 80(C), pages 1-14.
- Rudolf Vetschera, 2003. "Experimentation and Learning in Repeated Cooperation," Computational and Mathematical Organization Theory, Springer, vol. 9(1), pages 37-60, May.
- Dias, Luis C. & Climaco, Joao N., 2005. "Dealing with imprecise information in group multicriteria decisions: a methodology and a GDSS architecture," European Journal of Operational Research, Elsevier, vol. 160(2), pages 291-307, January.
- Kwak, Hyokjin & Anderson, Rolph E. & Leigh, Thomas W. & Bonifield, Scott D., 2019. "Impact of salesperson macro-adaptive selling strategy on job performance and satisfaction," Journal of Business Research, Elsevier, vol. 94(C), pages 42-55.
- Tang, Liang & Jing, Ke & He, Jie & Stanley, H. Eugene, 2016. "Robustness of assembly supply chain networks by considering risk propagation and cascading failure," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 459(C), pages 129-139.
- Ye Jin Lee & Kwangsoo Shin & Eungdo Kim, 2019. "The Influence of a Firm’s Capability and Dyadic Relationship of the Knowledge Base on Ambidextrous Innovation in Biopharmaceutical M&As," Sustainability, MDPI, vol. 11(18), pages 1-17, September.
- Andrea Lučić, 2020. "Measuring Sustainable Marketing Orientation—Scale Development Process," Sustainability, MDPI, vol. 12(5), pages 1-22, February.
- Seyyed Mohammad Seyyed Alizadeh Ganji & Mohammad Hayati, 2016. "Identifying and Assessing the Risks in the Supply Chain," Modern Applied Science, Canadian Center of Science and Education, vol. 10(6), pages 1-74, June.
- Breitmoser, Yves & Schweighofer-Kodritsch, Sebastian, 2019.
"Obviousness around the clock,"
Discussion Papers, Research Unit: Market Behavior
SP II 2019-203, WZB Berlin Social Science Center.
- Breitmoser, Yves & Schweighofer-Kodritsch, Sebastian, 2019. "Obviousness Around the Clock," Rationality and Competition Discussion Paper Series 151, CRC TRR 190 Rationality and Competition.
- Mustajoki, Jyri & Hamalainen, Raimo P. & Lindstedt, Mats R.K., 2006. "Using intervals for global sensitivity and worst-case analyses in multiattribute value trees," European Journal of Operational Research, Elsevier, vol. 174(1), pages 278-292, October.
- Adiel Teixeira Almeida & Eduarda Asfora Frej & Lucia Reis Peixoto Roselli, 2021. "Combining holistic and decomposition paradigms in preference modeling with the flexibility of FITradeoff," Central European Journal of Operations Research, Springer;Slovak Society for Operations Research;Hungarian Operational Research Society;Czech Society for Operations Research;Österr. Gesellschaft für Operations Research (ÖGOR);Slovenian Society Informatika - Section for Operational Research;Croatian Operational Research Society, vol. 29(1), pages 7-47, March.
- Helmig, Bernd & Hinz, Vera & Ingerfurth, Stefan, 2014. "Extending Miles & Snow's strategy choice typology to the German hospital sector," Health Policy, Elsevier, vol. 118(3), pages 363-376.
- Billette de Villemeur, Etienne & Versaevel, Bruno, 2019.
"One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry,"
Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
- Billette de Villemeur, Etienne & Versaevel, Bruno, 2017. "One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry," MPRA Paper 76903, University Library of Munich, Germany.
- Etienne Billette de Villemeur & Bruno Versaevel, 2019. "One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry," Post-Print hal-02107357, HAL.
- Bruno Versaevel, 2018. "One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry," Post-Print halshs-01960435, HAL.
- Bruno Versaevel, 2018. "One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry," Post-Print halshs-01960426, HAL.
- Ngwenyama, Ojelanki K. & Bryson, Noel, 1999. "Eliciting and mapping qualitative preferences to numeric rankings in group decision making," European Journal of Operational Research, Elsevier, vol. 116(3), pages 487-497, August.
- Rika Ampuh Hadiguna, 2012. "Decision support framework for risk assessment of sustainable supply chain," International Journal of Logistics Economics and Globalisation, Inderscience Enterprises Ltd, vol. 4(1/2), pages 35-54.
- Longinos Marín & Alicia Rubio & Salvador Ruiz de Maya, 2012. "Competitiveness as a Strategic Outcome of Corporate Social Responsibility," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 19(6), pages 364-376, November.
- Meimei Xia & Jian Chen & Juliang Zhang, 2015. "Multi-criteria decision making based on relative measures," Annals of Operations Research, Springer, vol. 229(1), pages 791-811, June.
- Jean-François Hennart, 2020. "More than intent: A bundling model of MNE–SME interactions," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 51(7), pages 1176-1194, September.
- Daron Acemoglu & Joshua Linn, 2004.
"Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 119(3), pages 1049-1090.
- Daron Acemoglu & Joshua Linn, 2003. "Market Size in Innovation: Theory and Evidence From the Pharmaceutical Industry," NBER Working Papers 10038, National Bureau of Economic Research, Inc.
- Daron Acemoglu & Joshua Linn, 2004. "Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry," Levine's Working Paper Archive 228400000000000002, David K. Levine.
More about this item
Keywords
Supply chain; Effectiveness; Cross industry; Regenerative medicine; Umbilical cord blood; Pharmaceutical; Cell therapy; Allogeneic; Autologous; Case study;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:proeco:v:149:y:2014:i:c:p:211-225. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/ijpe .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.